Live Breaking News & Updates on Office of product evaluation

Stay informed with the latest breaking news from Office of product evaluation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Office of product evaluation and stay connected to the pulse of your community

Restless Sleep: Recall Impacts Millions of Sleep Apnea Patients Worldwide

Restless Sleep: Recall Impacts Millions of Sleep Apnea Patients Worldwide
nbcmiami.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcmiami.com Daily Mail and Mail on Sunday newspapers.

Mchenry-county , Illinois , United-states , Chicago , Americans , William-maisel , Mario-fante , Dena-young , Shawn-woodruff , Office-of-product-evaluation , Drug-administration , Young

Restless Sleep: Recall Impacts Millions of Sleep Apnea Patients Worldwide

Restless Sleep: Recall Impacts Millions of Sleep Apnea Patients Worldwide
nbcbayarea.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcbayarea.com Daily Mail and Mail on Sunday newspapers.

Mchenry-county , Illinois , United-states , Chicago , Americans , William-maisel , Mario-fante , Dena-young , Shawn-woodruff , Office-of-product-evaluation , Drug-administration , Young

AGG Food & Drug Newsletter - June 2021 | Arnall Golden Gregory LLP

AGG Food & Drug Newsletter - June 2021 | Arnall Golden Gregory LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

United-states , Minsk , Belarus-general- , Belarus , American , Genevievem-razick , Jeff-spicoli , William-maisel , Sean-penn , Office-of-product-evaluation , Radiological-health , Arnall-golden-gregory

Sooner or Later, Everything Old is New Again: FDA Issues Draft Guidance Addressing Remanufacturing of Medical Devices | Arnall Golden Gregory LLP

Sooner or Later, Everything Old is New Again: FDA Issues Draft Guidance Addressing Remanufacturing of Medical Devices | Arnall Golden Gregory LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

United-states , American , William-maisel , Office-of-product-evaluation , Radiological-health , Drug-administration , Medical-devices , Product-evaluation , White-paper , Evaluating-whether-activities , Draft-guidance , Discussion-paper-seeking-feedback

FDA Suspends Review for Non-COVID-19 In Vitro Diagnostics (IVD) Submissions and Expects Review Delays in Non-IVD Products | Womble Bond Dickinson


[author: Heather Hatcher, Ph.D.]
A year into the current public health emergency, the FDA’s Center for Devices and Radiological Health (CDRH) announced on Thursday, April 15, 2021, that the center is “prioritizing and triaging our work using existing resources in order to focus on our COVID-19 response, resulting in delays in some other work areas.” Dr. Jeff Shuren, Director, CDRH, and Dr. William Maisel, Director, Office of Product Evaluation and Quality at CDRH, reported that the astounding numbers of pre-EUA and EUA submissions received for COVID-19 tests and collection kits created a significant workload that has strained the center’s resources in the review of in vitro diagnostic (IVD) files. Shuren and Maisel report that current pre-EUA and EUA submissions under active review across the center exceeds 600 with an average receipt of more than 40 new pre-EUA and EUA submissions per week in addition to non-COVID-related submissions. Every office in CDRH has been heavily impacted and staff and resources have been reallocated from product areas less impacted to those with increased submission volume. CDRH staff have been working nights and weekends, and Congress has approved one-time funding support to hire temporary employees and use third party reviewers.

William-maisel , Jeff-shuren , Office-of-product-evaluation , Radiological-health , Product-evaluation , Medical-device-user-fee-amendments , வில்லியம்-மைசேல் , அலுவலகம்-ஆஃப்-ப்ராடக்ட்-மதிப்பீடு , கதிரியக்கவியல்-ஆரோக்கியம் , ப்ராடக்ட்-மதிப்பீடு , மருத்துவ-சாதனம்-பயனர்-கட்டணம்-திருத்தங்கள் ,

FDA Alerts Public about Improper Use of Thermal Imaging Devices; Warns Firms for Illegally Offering Thermal Imaging Systems for Sale


FDA Alerts Public about Improper Use of Thermal Imaging Devices; Warns Firms for Illegally Offering Thermal Imaging Systems for Sale
News provided by
Share this article
Share this article
SILVER SPRING, Md., March 4, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration today alerted consumers, health care providers and other users of thermal imaging systems intended to measure human body temperature—also known as telethermographic systems, infrared thermographs, thermal cameras, and "fever cameras"—that improper use of the systems may provide inaccurate temperature readings due to a variety of factors. Additionally, the FDA issued several Warning Letters to certain firms offering unapproved, uncleared, and unauthorized thermal imaging systems for sale.

United-states , American , William-maisel , Abby-capobianco , Office-of-product-evaluation , Radiological-health , Opgal-optronic-industries , Drug-administration , Kogniz-inc , Warning-letters-to-certify-global-inc , Warning-letters , Chief-medical-officer

FDA alerts consumers about improper use of thermal imaging systems, warns firms for marketing unapproved devices


FDA alerts consumers about improper use of thermal imaging systems, warns firms for marketing unapproved devices
The U.S. Food and Drug Administration today alerted consumers, health care providers and other users of thermal imaging systems intended to measure human body temperature—also known as telethermographic systems, infrared thermographs, thermal cameras, and "fever cameras"—that improper use of the systems may provide inaccurate temperature readings due to a variety of factors.
Additionally, the FDA issued several Warning Letters to certain firms offering unapproved, uncleared, and unauthorized thermal imaging systems for sale.
While thermal imaging is not an effective diagnostic device for COVID-19, it can determine if someone has an elevated temperature, which can be an important risk management tool during the pandemic when used properly."

United-states , American , William-maisel , Emily-henderson , Office-of-product-evaluation , Opgal-optronic-industries-ltd , Radiological-health , Drug-administration , Kogniz-inc , Warning-letters-to-certify-global-inc , Warning-letters , Chief-medical-officer